Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia

Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high rates of thrombosis-related morbidity and mortality. HIT is a long-recognized reaction to the administration of the common parenterally admin...

Full description

Saved in:

Bibliographic Details
Published in:	Seminars in thrombosis and hemostasis Vol. 49; no. 5; p. 444
Main Authors:	Selvadurai, Maria V, Favaloro, Emmanuel J, Chen, Vivien M
Format:	Journal Article
Language:	English
Published:	United States 01.07.2023
Subjects:	COVID-19 Humans Platelet Factor 4 Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia Thrombosis Vaccines
ISSN:	1098-9064, 1098-9064
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high rates of thrombosis-related morbidity and mortality. HIT is a long-recognized reaction to the administration of the common parenterally administered anticoagulant heparin (or its derivatives), while VITT is a new, distinct syndrome occurring in response to adenovirus-based vaccines against coronavirus disease 2019 and potentially other types of vaccines. A feature of both HIT and VITT is paradoxical thrombosis despite a characteristic low platelet count, mediated by the presence of platelet-activating antibodies to platelet factor 4. Several additional factors have also been suggested to contribute to clot formation in HIT and/or VITT, including monocytes, tissue factor, microparticles, endothelium, the formation of neutrophil extracellular traps, complement, procoagulant platelets, and vaccine components. In this review, we discuss the literature to date regarding mechanisms contributing to thrombosis in both HIT and VITT and explore the pathophysiological similarities and differences between the two conditions.
AbstractList	Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high rates of thrombosis-related morbidity and mortality. HIT is a long-recognized reaction to the administration of the common parenterally administered anticoagulant heparin (or its derivatives), while VITT is a new, distinct syndrome occurring in response to adenovirus-based vaccines against coronavirus disease 2019 and potentially other types of vaccines. A feature of both HIT and VITT is paradoxical thrombosis despite a characteristic low platelet count, mediated by the presence of platelet-activating antibodies to platelet factor 4. Several additional factors have also been suggested to contribute to clot formation in HIT and/or VITT, including monocytes, tissue factor, microparticles, endothelium, the formation of neutrophil extracellular traps, complement, procoagulant platelets, and vaccine components. In this review, we discuss the literature to date regarding mechanisms contributing to thrombosis in both HIT and VITT and explore the pathophysiological similarities and differences between the two conditions.Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high rates of thrombosis-related morbidity and mortality. HIT is a long-recognized reaction to the administration of the common parenterally administered anticoagulant heparin (or its derivatives), while VITT is a new, distinct syndrome occurring in response to adenovirus-based vaccines against coronavirus disease 2019 and potentially other types of vaccines. A feature of both HIT and VITT is paradoxical thrombosis despite a characteristic low platelet count, mediated by the presence of platelet-activating antibodies to platelet factor 4. Several additional factors have also been suggested to contribute to clot formation in HIT and/or VITT, including monocytes, tissue factor, microparticles, endothelium, the formation of neutrophil extracellular traps, complement, procoagulant platelets, and vaccine components. In this review, we discuss the literature to date regarding mechanisms contributing to thrombosis in both HIT and VITT and explore the pathophysiological similarities and differences between the two conditions. Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high rates of thrombosis-related morbidity and mortality. HIT is a long-recognized reaction to the administration of the common parenterally administered anticoagulant heparin (or its derivatives), while VITT is a new, distinct syndrome occurring in response to adenovirus-based vaccines against coronavirus disease 2019 and potentially other types of vaccines. A feature of both HIT and VITT is paradoxical thrombosis despite a characteristic low platelet count, mediated by the presence of platelet-activating antibodies to platelet factor 4. Several additional factors have also been suggested to contribute to clot formation in HIT and/or VITT, including monocytes, tissue factor, microparticles, endothelium, the formation of neutrophil extracellular traps, complement, procoagulant platelets, and vaccine components. In this review, we discuss the literature to date regarding mechanisms contributing to thrombosis in both HIT and VITT and explore the pathophysiological similarities and differences between the two conditions.
Author	Favaloro, Emmanuel J Selvadurai, Maria V Chen, Vivien M
Author_xml	– sequence: 1 givenname: Maria V surname: Selvadurai fullname: Selvadurai, Maria V organization: ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia – sequence: 2 givenname: Emmanuel J surname: Favaloro fullname: Favaloro, Emmanuel J organization: School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, NSW, Australia – sequence: 3 givenname: Vivien M surname: Chen fullname: Chen, Vivien M organization: Department of Haematology, Concord Repatriation General Hospital and NSW Health Pathology, Sydney, NSW, Australia
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/36706782$$D View this record in MEDLINE/PubMed
BookMark	eNplkL1PwzAUxC1URD9gZUQZWQLPdmI_j6jio1IRS2GNHMdWjRo7xMnQ_55KtAiJW-5J97s33JxMQgyWkGsKdxTK8j7lAAXPqRSUCXVGZhQU5gpEMflzT8k8pU8AWiCwCzLlQoKQyGYkvVqz1cGnNmXRZZttH9s6Jp8yH7IX2-neh3wVmtHY5pSa_RA7G7zOdGiyD22MD_YXWrXtGOyJHbz5V7sk507vkr06-oK8Pz1uli_5-u15tXxY54ZzPuQorGgoopauRMlMKQs0zUHaYYO6kM5yVuoaS-dQAUpXi5oqWRuuXAGcLcjtz9-uj1-jTUPV-mTsbqeDjWOqmJRQSARQB_TmiI51a5uq632r-311Gop9A9WGbls
CitedBy_id	crossref_primary_10_1182_blood_2023022346 crossref_primary_10_3390_healthcare12151537 crossref_primary_10_1016_j_jtha_2023_06_027 crossref_primary_10_1055_s_0045_1810021 crossref_primary_10_1016_j_bioorg_2024_107463 crossref_primary_10_1055_s_0043_1761487 crossref_primary_10_1182_bloodadvances_2024014167 crossref_primary_10_1055_s_0043_57033 crossref_primary_10_3390_jcm14082591 crossref_primary_10_17749_2313_7347_ob_gyn_rep_2025_610 crossref_primary_10_1055_a_2413_4345 crossref_primary_10_1097_MD_0000000000042696 crossref_primary_10_1055_s_0044_1782197 crossref_primary_10_1055_s_0043_1762576 crossref_primary_10_1055_s_0044_1787989 crossref_primary_10_1055_s_0045_1806855 crossref_primary_10_1055_s_0045_1807739
ContentType	Journal Article
Copyright	Thieme. All rights reserved.
Copyright_xml	– notice: Thieme. All rights reserved.
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1055/s-0043-1761269
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1098-9064
ExternalDocumentID	36706782
Genre	Journal Article Review
GroupedDBID	--- .GJ 0R~ 123 1UC 4.4 53G 5RE 5~~ AAIWL AAKAS AAQQT ABJNI ABOCM ABZLV ACGFO ACGFS ACNUY ADZCM AENEX AEVEF AGCGI AHRAW AHRSK AIVKU AJGCD AKJTW ALMA_UNASSIGNED_HOLDINGS BPGNG C45 CAG CGR COF CS3 CUY CVF DU5 EBS ECM EIF EJD EXEOM F5P H13 IY8 J5H N9A NPM O9- OVD P2P Q3R QTC RIG ROL RTC TEORI TWZ UDS YFH ZGI ZXP 7X8
ID	FETCH-LOGICAL-c333t-86e6d188a7f5872c5748cddddaf8d8a47fe325ab85ff89087fb6b197bc39f4032
IEDL.DBID	7X8
ISICitedReferencesCount	18
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000923079500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1098-9064
IngestDate	Fri Jul 11 14:43:41 EDT 2025 Mon Jul 21 05:50:08 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	5
Language	English
License	Thieme. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c333t-86e6d188a7f5872c5748cddddaf8d8a47fe325ab85ff89087fb6b197bc39f4032
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
PMID	36706782
PQID	2770478009
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2770478009 pubmed_primary_36706782
PublicationCentury	2000
PublicationDate	2023-07-01
PublicationDateYYYYMMDD	2023-07-01
PublicationDate_xml	– month: 07 year: 2023 text: 2023-07-01 day: 01
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Seminars in thrombosis and hemostasis
PublicationTitleAlternate	Semin Thromb Hemost
PublicationYear	2023
SSID	ssj0014802
Score	2.4695916
SecondaryResourceType	review_article
Snippet	Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	444
SubjectTerms	COVID-19 Humans Platelet Factor 4 Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia Thrombosis Vaccines
Title	Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia
URI	https://www.ncbi.nlm.nih.gov/pubmed/36706782 https://www.proquest.com/docview/2770478009
Volume	49
WOSCitedRecordID	wos000923079500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTC-1FeMhKr1TS2Y3tCCFGVoVWHgrpFtmOLDCSlLkj8e-w86ICEkMiQJT4ncu58Z3_n-wC44Up6MxIUZV5dEOlLhRRjAkkTCWN9fG-Iqsgm2HjMZzMxaTbcXJNW2c6J1USdlTrskfdixkIhGR8S3M7fUGCNCuhqQ6GxDjrYhzJBq9lshSIQ3uQcCm_U3ve2RRsp7TlU4c59v4qPk1_Cy8rNDHb_-4F7YKcJMOFdrRH7YM0UB2Br1EDoh8CNTDjsm7tXB0sLpy-L8lWVLncwL-DQBFLCAgVCD22y9qn-XAaWrVxCWWTwWerQ1Xejx3DExLRt_Wt_iB2Bp8HD9H6IGuYFpDHGS8QTk2R9ziWzlLNYU0a4zvwlLc-4JMwaHFOpOLWWi4gzqxLVF0xpLCyJcHwMNoqyMKcAqoA8SuI7s5rYRAnMJaYs0l6EGJF0wXU7nKnX7ABXyMKU7y5dDWgXnNT_JJ3XJTjSUHbOu9n47A_S52A7cMTXObYXoGO9XZtLsKk_lrlbXFUq4-_jyegLSW3NcQ
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+of+Thrombosis+in+Heparin-Induced+Thrombocytopenia+and+Vaccine-Induced+Immune+Thrombotic+Thrombocytopenia&rft.jtitle=Seminars+in+thrombosis+and+hemostasis&rft.au=Selvadurai%2C+Maria+V&rft.au=Favaloro%2C+Emmanuel+J&rft.au=Chen%2C+Vivien+M&rft.date=2023-07-01&rft.issn=1098-9064&rft.eissn=1098-9064&rft.volume=49&rft.issue=5&rft.spage=444&rft_id=info:doi/10.1055%2Fs-0043-1761269&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-9064&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-9064&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-9064&client=summon